Your browser doesn't support javascript.
loading
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.
Ferrari, Roberto; Aguiar, Carlos; Alegria, Eduardo; Bonadonna, Riccardo C; Cosentino, Francesco; Elisaf, Moses; Farnier, Michel; Ferrières, Jean; Filardi, Pasquale Perrone; Hancu, Nicolae; Kayikcioglu, Meral; Mello E Silva, Alberto; Millan, Jesus; Reiner, Zeljko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margus; Vrablik, Michal; Zambon, Alberto; Zamorano, José Luis; Catapano, Alberico L.
Affiliation
  • Ferrari R; Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy.
  • Aguiar C; Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, EPE, Carnaxide, Portugal.
  • Alegria E; Cardiology Department, Policlínica Gipuzkoa, San Sebastián, Spain.
  • Bonadonna RC; Division of Endocrinology, Department of Clinical and Experimental Medicine, University of Parma and Azienda Ospedaliera Universitaria of Parma, Parma, Italy.
  • Cosentino F; Cardiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Elisaf M; Department of Internal Medicine, University of Ioannina Medical School, Ioannina, Greece.
  • Farnier M; Lipid Clinic, Point Médical, Dijon, France.
  • Ferrières J; Cardiovascular Preventive Department, Department of Cardiology, Toulouse University School of Medicine, Rangueil Hospital, Toulouse, France.
  • Filardi PP; Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
  • Hancu N; Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Kayikcioglu M; Department of Cardiology, Ege University Medical School, Izmir, Turkey.
  • Mello E Silva A; Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental, EPE, Lisbon, Portugal.
  • Millan J; Nova Medical School, Faculdade de Ciências Médicas, Lisbon, Portugal.
  • Reiner Z; Internal Medicine Service, Hospital General Universitario Gregorio Marañón, Facultad de Medicina de la Universidad Complutense, Madrid, Spain.
  • Tokgozoglu L; Department of Internal Medicine, University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Valensi P; Hacettepe University, Ankara, Turkey.
  • Viigimaa M; Department of Endocrinology Diabetology Nutrition, Jean Verdier Hospital, APHP, Paris Nord University, CRNH-IdF, CINFO, Bondy, France.
  • Vrablik M; Institute of Cardiovascular Medicine, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia.
  • Zambon A; Third Department of Internal Medicine, First Medical Faculty, Charles University, Prague, Czech Republic.
  • Zamorano JL; Clinica Medica, Department of Medicine, University of Padova, Padova, Italy.
  • Catapano AL; Head of Cardiology, University Alcala de Henares, Hospital Ramón y Cajal, Madrid, Spain.
Eur Heart J Suppl ; 18(Suppl C): C2-C12, 2016 Apr 12.
Article de En | MEDLINE | ID: mdl-28533705
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Etiology_studies / Risk_factors_studies Langue: En Journal: Eur Heart J Suppl Année: 2016 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Etiology_studies / Risk_factors_studies Langue: En Journal: Eur Heart J Suppl Année: 2016 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni